Former Bausch + Lomb CEO Saunders to head Forest; Icahn approves

After Brent Saunders saw Bausch + Lomb through a transformation that made the company attractive to recent acquirer Valeant Pharmaceuticals, industry observers wondered where the Schering-Plough veteran would work his magic next, and now they have their answer: Forest Laboratories.